Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for paltusotine, the first once-daily, oral ...
Dr. Crystal Aguh, a dermatologist and director of Johns Hopkins Medicine’s ethnic skin program, has had major breakthroughs in her research on the low-dose oral diabetes medication metformin’s effect ...
For the last few days, you’ve seen multiple reports on fentanyl use and the dangers that come with it. There are multiple resources for people suffering from ...